SOPH
HEALTHCARESOPHiA Genetics SA
Live · NASDAQ · May 9, Close
What's Moving SOPH Today?
No stock-specific AI insight has been generated for SOPH yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$5.02
Fundamentals
Trading
SOPH News
20 articles- SOPHiA GENETICS S.A. Q1 2026 Earnings Call SummaryMoby·May 5, 2026
- SOPHiA GENETICS Q1 Earnings Call HighlightsMarketbeat·May 5, 2026
- SOPHiA Genetics (SOPH) Q1 2026 Earnings TranscriptMotley Fool·May 5, 2026
- BTIG Raises its Price Target on SOPHiA GENETICS (SOPH) to $8Yahoo Finance·May 5, 2026
- SOPHiA GENETICS Reports First Quarter 2026 ResultsYahoo Finance·May 5, 2026
- Tempus AI Stock Before Q1 Earnings Release: To Buy or Not to Buy?Yahoo Finance·Apr 27, 2026
- How The SOPHiA GENETICS (NasdaqGS:SOPH) Narrative Is Shifting With New Fair Value TargetsYahoo Finance·Apr 26, 2026
- SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026Yahoo Finance·Apr 21, 2026
- Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026Yahoo Finance·Apr 16, 2026
- What's Driving TEM Data and Applications Arm's Robust Growth?Yahoo Finance·Apr 7, 2026
- How The SOPHiA GENETICS (SOPH) Narrative Is Shifting With Recalibrated Growth And Valuation AssumptionsYahoo Finance·Mar 27, 2026
- Sophia Genetics SA (SOPH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...Yahoo Finance·Mar 5, 2026
- SOPHiA GENETICS Q4 Earnings Call HighlightsMarketbeat·Mar 3, 2026
- SOPHiA GENETICS S.A. Q4 2025 Earnings Call SummaryMoby·Mar 3, 2026
- SOPHiA GENETICS (SOPH) Q4 2025 Earnings TranscriptMotley Fool·Mar 3, 2026
- SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 ResultsYahoo Finance·Mar 3, 2026
- Why The SOPHiA GENETICS (SOPH) Narrative Is Shifting On Richer Valuation And Growth ExpectationsYahoo Finance·Feb 26, 2026
- SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care ConferenceYahoo Finance·Feb 25, 2026
- Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy?Yahoo Finance·Feb 18, 2026
- SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026Yahoo Finance·Feb 17, 2026
All 20 articles loaded
Price Data
52-Week Range
$5.02
Fundamentals
Trading
About SOPHiA Genetics SA
Sophia Genetics SA (SOPH) is a trailblazer in data-driven medicine, specializing in advanced genomic and clinical data analytics aimed at improving patient outcomes. Leveraging state-of-the-art machine learning algorithms, the company offers a robust platform that empowers hospitals and laboratories to decode complex genomic information, thereby enabling personalized treatment approaches, particularly in oncology, rare diseases, and hereditary conditions. With a strong global presence and strategic alliances with leading healthcare institutions, Sophia Genetics is dedicated to revolutionizing healthcare through precision medicine, reinforcing its status as a key player in the genomics sector.